Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian M Capitini

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|June 24, 2026
Biocompatible Glycoconjugation Enables Sensitive In Vivo Cell Tracking by PET/CTNathan Clemons, Anna S Thickens, Liudmila Lambert Lepesevich, et al.
Leukemia|May 25, 2019
PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cellsFen Zhu, Hui Guo, Paul D Bates, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Cell Reports|August 17, 2022
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironmentAthanasios Papadas, Gauri Deb, Alexander Cicala, et al.
Science Advances|December 5, 2025
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer modelsMd Mahfuzur Rahman, Andrea Pennati, Tavus Atajanova, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factorsSasha E Stanton, Kristin G Anderson, Tullia C Bruno, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcomaMonica M Cho, Longzhen Song, Aicha E Quamine, et al.
Nature Communications|October 21, 2023
Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV<sup>±</sup> cancerJose M Ayuso, Mehtab Farooqui, María Virumbrales-Muñoz, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 24, 2026
Biocompatible Glycoconjugation Enables Sensitive In Vivo Cell Tracking by PET/CTNathan Clemons, Anna S Thickens, Liudmila Lambert Lepesevich, et al.
Leukemia|May 25, 2019
PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cellsFen Zhu, Hui Guo, Paul D Bates, et al.
Blood|September 22, 2023
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphomaYunxia Liu, Shuichi Kimpara, Nguyet M Hoang, et al.
Cell Reports|August 17, 2022
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironmentAthanasios Papadas, Gauri Deb, Alexander Cicala, et al.
Science Advances|December 5, 2025
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer modelsMd Mahfuzur Rahman, Andrea Pennati, Tavus Atajanova, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factorsSasha E Stanton, Kristin G Anderson, Tullia C Bruno, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Journal for Immunotherapy of Cancer|December 12, 2025
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplantAicha E Quamine, Evan L Dray, Nicholas R Mohrdieck, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcomaMonica M Cho, Longzhen Song, Aicha E Quamine, et al.
Nature Communications|October 21, 2023
Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV<sup>±</sup> cancerJose M Ayuso, Mehtab Farooqui, María Virumbrales-Muñoz, et al.
Pageof 10